SKMC Office of Continuing Medical Education
Parathyroid and Osteoporosis 2014: New Advances in the Management of Parathyroid Disease & Osteoporosis
Friday, November 14, 2014
Bluemle Life Sciences Building - Thomas Jefferson University Campus
233 South 10th Street
Philadelphia PA, 19107
This innovative course will be of interest to all specialists working in the field of osteoporosis, hyperparthyroidism and bone disease: general and endocrine surgeons, otolaryngologists, endocrinologists, medical imagers, pathologists, internal medicine physicians, gynecologists, family physicians, nurses and trainees.
This CME Conference offers participants a unique opportunity to witness experts deliberate and debate how they would manage patients with hyperparathyroidism or osteoporosis. This active learning format features critical deliberations regarding patient cases, clinical findings, differential diagnoses and management plan options. Participants will examine cases from multiple perspectives, and gain in-depth understanding to how experienced healthcare providers approach difficult patient care decisions. Keynote Lectures from leading practitioners provide evidence for care decisions discussed in panels.
The combined format of live debate and didactic presentations will allow participants to observe and question faculty practitioners as they deal with real patient problems and demonstrate how to apply new information and evidence based guidelines into their practices.
This course will evaluate the recent advances in diagnostic and therapeutic approaches to Parathyroid Disease and Osteoporosis that have altered traditional management paradigms. The latest evidence-based guidelines from the American Thyroid Association regarding Hyperparathyroidism and Osteoporosis will be reviewed and practitioners will be provided with an array of contemporary management elements with which to approach patients with these difficulties.
Featured Keynote Speakers:
James Norman, MD, FACS, FACE
Nelson B. Watts, MD
Jefferson Medical College of Thomas Jefferson University designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Statement:
2nd Annual Thomas Jefferson University - Seoul National University Endoscopic Skull Base Symposium
September 6-7, 2013
The Division of Endocrinology, Diabetes and Metabolic Diseases provides comprehensive care for patients with Type I and Type II diabetes mellitus, obesity and thyroid nodules and goiters. Expert evaluation and management of other hormonal and glandular disorders involving the thyroid, pituitary, parathyroid and adrenal glands, as well as osteoporosis, other bone disorders and calcium metabolism and disorders of cholesterol and triglyceride metabolism.
- make transformational discoveries of the cellular and molecular biology of the malignant process and the individual's and society's response to it
- effectively translate the latest research discoveries and clinical trials to provide the highest quality of care to all patients including those of diverse ethnic and racial populations
- provide expert and humanitarian care to cancer patients, their families, and those at risk
The Department of Otolaryngology - Head and Neck Surgery at Jefferson University Hospital is the regional leader in minimally invasive thyroid and parathyroid surgery. The department serves a large and varied patient community, including children, and features specialized centers and programs dedicated to hearing and balance disorders, taste and smell disorders, reconstructive and facial plastic surgery, and, uniquely, the care of the professional performing or voice-over artist. For our multidisciplinary approach to head and neck cancer, we collaborate closely with Jefferson University Hospital's Kimmel Cancer Center and Center for Integrative Medicine
The Kimmel Cancer Center (KCC) was founded in 1991 and is one of a select group of cancer centers in the nation designated by the National Cancer Institute. Today, the KCC has approximately 150 members that include physicians and scientists dedicated to discovery and development of novel approaches for cancer treatment. The mission of the Kimmel Cancer Center, a National Cancer Institute-designated cancer center, is to: